News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Priorities of ESTRO for engagement within the EURAMED framework
ESTRO/X
Jan 9, 2025, 16:32

Priorities of ESTRO for engagement within the EURAMED framework

ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X:

“Learn how ESTRO aligns with the EURAMED roadmap to advocate for radioprotection.

Read this article that outlines ESTRO’s strategic priorities for collaboration and innovation in radiation safety and optimised cancer care across Europe.”

More posts featuring ESTRO.

cancer ESTRO EURAMED European SocieTy for Radiotherapy and Oncology OncoDaily Oncology radiation safety
Special Coverage
Blog
Jan 9, 2025, 16:32
Priorities of ESTRO for engagement within the EURAMED framework
Blog
Jan 9, 2025, 16:29
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Blog
Jan 9, 2025, 16:22
Isabel Preeshagul: Survey on addressing barriers to clinical trial accrual in patients with lung cancer
Blog
Jan 9, 2025, 16:20
Saddened to learn of the unexpected passing of Prof. Petra Feyer - MASCC
Blog
Jan 9, 2025, 16:07
Eric Racine: The Patient Advocacy Voices Podcast is Back for 2025
Blog
Jan 9, 2025, 16:04
Rachit Khandelwal: New insights on treating infant ALL
Science
Jan 9, 2025, 16:02
Sid Yadav: Changing the landscape of VUS in BRCA2
Insight
Jan 9, 2025, 15:58
Dana-Farber Cancer Institute has officially launched the Center for RAS Therapeutics
Science
Jan 9, 2025, 15:52
Moazzam Shahzad: The role of Allo-HCT in therapy-related myeloid neoplasms
Blog
Jan 9, 2025, 15:50
Elvina Almuradova: Dual-HER2 inhibition with trastuzumab + pertuzumab in HER2-positive mCRC
Insight
Jan 9, 2025, 15:48
Kristina Jankovic: 12-year follow-up of the C9741 trial
Blog
Jan 9, 2025, 15:48
Michael Sapienza: Early-onset colorectal cancer incidence rates are rising in 27 of 50 countries/territories worldwide